+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Aurora Kinase B global market

Aurora Kinase B global market

Global Aurora Kinase B Market Research Report 2025

This report on the global aurora kinase b market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging trends, regional perfo

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Aurora Kinase B Market Report (2025–2035)

Market Prediction

Chem Reports predicts that the Aurora Kinase B Market was valued at USD xxxx units in 2024 and is expected to reach USD xxxx units by 2035, growing at a CAGR of xx% globally.

The Global Aurora Kinase B Market Report 2020 provides an extensive industry analysis of development components, patterns, flows, and market sizes. It calculates present and past market values to forecast potential market performance during the forecast period (2025–2035).
This research study utilized both primary and secondary data sources, examining parameters such as government policy, market environment, competitive landscape, historical data, current trends, technological innovation, upcoming technologies, and technical progress in related industries.

Impact of COVID-19

Since the outbreak of COVID-19 in December 2019, the pandemic spread worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of COVID-19 significantly affected the Aurora Kinase B market in 2020, disrupting clinical trials, supply chains, and investment flows in oncology drug development.

Market Segmentation

By Type

  • AZD-2811
  • CS-2164
  • Danusertib
  • Ilorasertib
  • NMI-900
  • Others

By Application

  • Anaplastic Large Cell Lymphoma
  • Kidney Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Key Market Players

  • AbbVie Inc
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sanofi
  • Sareum Holdings Plc

The Aurora Kinase B market is projected to grow steadily from 2024 to 2035, driven by its role in oncology drug development. Aurora Kinase B inhibitors are critical in targeting cell division pathways, with applications across cancers such as lymphoma, kidney, lung, and prostate. Growth is supported by rising cancer prevalence, expanding clinical trials, and pharmaceutical innovation in kinase-targeted therapies.

Detailed Segmentation Analysis

By Type

  • AZD-2811 – AstraZeneca’s candidate, advancing in hematologic malignancies.
  • CS-2164 – Multi-target inhibitor with applications in solid tumors.
  • Danusertib – Investigated for multiple cancer types, including prostate and leukemia.
  • Ilorasertib – Dual kinase inhibitor with potential in advanced cancers.
  • NMI-900 – Novel candidate under clinical evaluation.
  • Others – Includes pipeline therapies from smaller biotech firms.

By Application

  • Anaplastic Large Cell Lymphoma: Key focus area for targeted therapies.
  • Kidney Cancer: Rising incidence driving demand for kinase inhibitors.
  • Lung Cancer: Largest oncology segment, strong adoption potential.
  • Prostate Cancer: Expanding use in advanced and resistant cases.
  • Others: Includes hematologic malignancies and rare cancers.

By Region

  • North America: Leading market, strong clinical trial activity and regulatory approvals.
  • Europe: Focus on precision oncology and reimbursement frameworks.
  • Asia-Pacific: Fastest-growing region, led by China and India’s oncology investments.
  • South America: Emerging demand in Brazil and Argentina.
  • Middle East & Africa: Niche adoption, growing cancer care infrastructure.

Porter’s Five Forces Analysis

  1. Threat of New Entrants: Low – High R&D and regulatory barriers limit entry.
  2. Bargaining Power of Suppliers: Moderate – Dependence on specialized biotech inputs.
  3. Bargaining Power of Buyers: High – Hospitals and governments demand cost efficiency and proven efficacy.
  4. Threat of Substitutes: Moderate – Other kinase inhibitors and immunotherapies compete.
  5. Industry Rivalry: High – Intense competition among global pharma leaders (AbbVie, Amgen, AstraZeneca, Sanofi).

SWOT Analysis

Strengths

  • Targeted mechanism of action in oncology.
  • Wide application across multiple cancer types.
  • Strong pipeline from leading pharmaceutical companies.

Weaknesses

  • High R&D costs and long development timelines.
  • Safety and efficacy concerns in clinical trials.

Opportunities

  • Rising global cancer prevalence.
  • Expansion in Asia-Pacific oncology markets.
  • Innovation in combination therapies with immuno-oncology drugs.

Threats

  • Competition from alternative therapies (CAR-T, checkpoint inhibitors).
  • Regulatory pressures on pricing and approvals.
  • Clinical trial failures impacting pipeline sustainability.

Trend Analysis

  • Precision Oncology Growth: Increasing demand for targeted therapies.
  • Combination Therapies: Aurora Kinase B inhibitors used alongside immunotherapies.
  • Pipeline Expansion: Strong clinical trial activity across regions.
  • Regional Growth: Asia-Pacific leading expansion due to healthcare investments.

Drivers & Challenges

Drivers

  • Rising global cancer incidence.
  • Expanding clinical trial activity.
  • Strong pharmaceutical investment in kinase inhibitors.

Challenges

  • High R&D and regulatory costs.
  • Competition from alternative oncology therapies.
  • Patient access and affordability issues.

Value Chain Analysis

  1. Raw Material Suppliers: Specialty biotech inputs and APIs.
  2. Manufacturers: Global leaders (AbbVie, Amgen, AstraZeneca, Sanofi, Sareum Holdings).
  3. Distributors: Hospitals, oncology centers, and specialty pharmacies.
  4. End Users: Cancer patients, healthcare providers, research institutions.
  5. Aftermarket Services: Clinical support, patient monitoring, and combination therapy programs.

 

 

1. Market Overview of Aurora Kinase B
    1.1 Aurora Kinase B Market Overview
        1.1.1 Aurora Kinase B Product Scope
        1.1.2 Market Status and Outlook
    1.2 Aurora Kinase B Market Size by Regions:
    1.3 Aurora Kinase B Historic Market Size by Regions
    1.4 Aurora Kinase B Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Aurora Kinase B Sales Market by Type
    2.1 Global Aurora Kinase B Historic Market Size by Type
    2.2 Global Aurora Kinase B Forecasted Market Size by Type
    2.3 AZD-2811
    2.4 CS-2164
    2.5 Danusertib
    2.6 Ilorasertib
    2.7 NMI-900
    2.8 Others
3. Covid-19 Impact Aurora Kinase B Sales Market by Application
    3.1 Global Aurora Kinase B Historic Market Size by Application
    3.2 Global Aurora Kinase B Forecasted Market Size by Application
    3.3 Anaplastic Large Cell Lymphoma
    3.4 Kidney Cancer
    3.5 Lung Cancer
    3.6 Prostate Cancer
    3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Aurora Kinase B Production Capacity Market Share by Manufacturers
    4.2 Global Aurora Kinase B Revenue Market Share by Manufacturers
    4.3 Global Aurora Kinase B Average Price by Manufacturers
5. Company Profiles and Key Figures in Aurora Kinase B Business
    5.1 AbbVie Inc
        5.1.1 AbbVie Inc Company Profile
        5.1.2 AbbVie Inc Aurora Kinase B Product Specification
        5.1.3 AbbVie Inc Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.2 Advenchen Laboratories LLC
        5.2.1 Advenchen Laboratories LLC Company Profile
        5.2.2 Advenchen Laboratories LLC Aurora Kinase B Product Specification
        5.2.3 Advenchen Laboratories LLC Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.3 Aeterna Zentaris Inc
        5.3.1 Aeterna Zentaris Inc Company Profile
        5.3.2 Aeterna Zentaris Inc Aurora Kinase B Product Specification
        5.3.3 Aeterna Zentaris Inc Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.4 Amgen Inc
        5.4.1 Amgen Inc Company Profile
        5.4.2 Amgen Inc Aurora Kinase B Product Specification
        5.4.3 Amgen Inc Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.5 AstraZeneca Plc
        5.5.1 AstraZeneca Plc Company Profile
        5.5.2 AstraZeneca Plc Aurora Kinase B Product Specification
        5.5.3 AstraZeneca Plc Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.6 Chipscreen Biosciences Ltd
        5.6.1 Chipscreen Biosciences Ltd Company Profile
        5.6.2 Chipscreen Biosciences Ltd Aurora Kinase B Product Specification
        5.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.7 Cielo Therapeutics Inc
        5.7.1 Cielo Therapeutics Inc Company Profile
        5.7.2 Cielo Therapeutics Inc Aurora Kinase B Product Specification
        5.7.3 Cielo Therapeutics Inc Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.8 Sanofi
        5.8.1 Sanofi Company Profile
        5.8.2 Sanofi Aurora Kinase B Product Specification
        5.8.3 Sanofi Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
    5.9 Sareum Holdings Plc
        5.9.1 Sareum Holdings Plc Company Profile
        5.9.2 Sareum Holdings Plc Aurora Kinase B Product Specification
        5.9.3 Sareum Holdings Plc Aurora Kinase B Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Aurora Kinase B Market Size
    6.2 North America Aurora Kinase B Key Players in North America
    6.3 North America Aurora Kinase B Market Size by Type
    6.4 North America Aurora Kinase B Market Size by Application
7. East Asia
    7.1 East Asia Aurora Kinase B Market Size
    7.2 East Asia Aurora Kinase B Key Players in North America
    7.3 East Asia Aurora Kinase B Market Size by Type
    7.4 East Asia Aurora Kinase B Market Size by Application
8. Europe
    8.1 Europe Aurora Kinase B Market Size
    8.2 Europe Aurora Kinase B Key Players in North America
    8.3 Europe Aurora Kinase B Market Size by Type
    8.4 Europe Aurora Kinase B Market Size by Application
9. South Asia
    9.1 South Asia Aurora Kinase B Market Size
    9.2 South Asia Aurora Kinase B Key Players in North America
    9.3 South Asia Aurora Kinase B Market Size by Type
    9.4 South Asia Aurora Kinase B Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Aurora Kinase B Market Size
    10.2 Southeast Asia Aurora Kinase B Key Players in North America
    10.3 Southeast Asia Aurora Kinase B Market Size by Type
    10.4 Southeast Asia Aurora Kinase B Market Size by Application
11. Middle East
    11.1 Middle East Aurora Kinase B Market Size
    11.2 Middle East Aurora Kinase B Key Players in North America
    11.3 Middle East Aurora Kinase B Market Size by Type
    11.4 Middle East Aurora Kinase B Market Size by Application
12. Africa
    12.1 Africa Aurora Kinase B Market Size
    12.2 Africa Aurora Kinase B Key Players in North America
    12.3 Africa Aurora Kinase B Market Size by Type
    12.4 Africa Aurora Kinase B Market Size by Application
13. Oceania
    13.1 Oceania Aurora Kinase B Market Size
    13.2 Oceania Aurora Kinase B Key Players in North America
    13.3 Oceania Aurora Kinase B Market Size by Type
    13.4 Oceania Aurora Kinase B Market Size by Application
14. South America
    14.1 South America Aurora Kinase B Market Size
    14.2 South America Aurora Kinase B Key Players in North America
    14.3 South America Aurora Kinase B Market Size by Type
    14.4 South America Aurora Kinase B Market Size by Application
15. Rest of the World
    15.1 Rest of the World Aurora Kinase B Market Size
    15.2 Rest of the World Aurora Kinase B Key Players in North America
    15.3 Rest of the World Aurora Kinase B Market Size by Type
    15.4 Rest of the World Aurora Kinase B Market Size by Application
16 Aurora Kinase B Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • AZD-2811
  • CS-2164
  • Danusertib
  • Ilorasertib
  • NMI-900
  • Others

By Application

  • Anaplastic Large Cell Lymphoma
  • Kidney Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Key Market Players

  • AbbVie Inc
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sanofi
  • Sareum Holdings Plc

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.